Moderna says FDA refuses to review its application for experimental flu shot

by admin | Feb 11, 2026 | Uncategorized

Spread the love

Moderna said the move is inconsistent with previous feedback from the FDA on the experimental influenza shot, called mRNA-1010.

Written by Albert Pham, News Curator and Blogger

Trump’s July Financial Disclosure Reveals Major Microsoft and Amazon Stock Trades

Trump’s July financial disclosure shows 1,156 securities transactions, including major Microsoft and Amazon stock sales worth up to $25 million each.

S&P 500 analysis shows technical sell signals are flashing despite Nvidia earnings hype.

The launch, which could happen as soon as Friday, comes ahead of “an IPO that’s basing so much” on narrative and symbolism.